LD-2 disclosure · 3rd Quarter - Report
NOVARTIS CORP
Client
- Name
- NOVARTIS CORP
- Description
- Manufacturer of vaccines and blood diagnostic products.
- Location
- District of Columbia · United States of America
Registrant
- Description
- Consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesCopyright/Patent/Trademark
S. 1145, H.R. 1908: Patent Reform Act of 2007. To amend title 35, United States Code, relating to the procurement, enforcement, and validity of patents. Lobbied to protect intellectual property rights. Sought amendments to insure the enforceability of patents.
LobbyistsSTEVE SYMMS · ROMANO ROMANI · mr EDWARD H BAXTER
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
H.R. 4703, S. 2467, H.R. 4991 - Vaccine Shortage Preparedness Act of 2008 S. 2464, H.R. 4992, H.R. 4704 - A bill to amend title XVIII of the Social Security Act to provide for coverage of federally recommended vaccines under Medicare, Part B S. 2465, H.R. 4702, H.R. 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program S. 2467, H.R. 4703, H.R. 4991 - a bill to amend the Social Security Act, the Federal Food, Drug and Cosmetic Act, and the Public Health Service Act to ensure a sufficient supply of vaccines and for other purposes Opposed efforts to amend the Federal Food, Drug and Cosmetic Act with respect to the sale of prescription drugs through the internet, and for other purposes. Lobbied to ensure that the Internet would not be used to import counterfeit and defective medical products H.R. 4705 - Vaccines for the Uninsured Adult Act of 2008 S. 3678 - Pandemic All Hazards Preparedness Act (Biodefense) S. 1505 - Affordable Biologics for Consumers Act S. 1695 Biologics Price Competition and Innovation Act of 2007, support enactment and follow-on Biologics legislation with amendments that strengthen FDA pathway and provide data exclusivity H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 H.R. 1038 Access to Life-Saving Medicine Act S. 623 - Access to Life-Saving Medicine Act General matters related to vaccine industry stability, pandemic preparedness, avian influenza
